Cases & Deals

LeaderMed Health Group expands pipeline with Aqualung license

Client(s) Leadermed Health Group Limited

Jones Day represented LeaderMed Health Group Limited in subscription of a convertible note and an exclusive license agreement with Aqualung Therapeutics Corporation ("Aqualung") to develop, manufacture, and commercialize Aqualung's clinical stage antibody product ALT-100 in eight Asian territories, including Greater China.